Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Here are some of the biggest movers of Monday.

Biogen Inc. shares BIIB rallied 5% following a full-day halt during the regular session as a Food and Drug Administration committee convened to vote on an approval recommendation for the biotech’s Alzheimer’s drug candidate it makes with Eisai Co. ESALF The committee voted unanimously... Biogen Inc.

Oracle Corp. ORCL stock rose 4%. It is slated to report fiscal fourth-quarter earnings after the bell on Monday. Analysts polled by FactSet expect the software giant to report adjusted earnings of $1.58 a share on sales of $13.7 billion. Teck Resources TECK TECK.B stock edged higher as Glencore GLEN lodged a bid for its coal unit, in addition to a $23 billion offer for the whole company.Carvana shares CVNA fell 1%, following a 21% downturn on Friday for the volatile used-car retailer.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 3. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인